Global Coronary Stent Market is segmented on the basis of type, mode of delivery, material, end user, and region.Stent is a tiny wire tube comprising mesh having props to unblock an artery and is left there permanently. When a coronary artery is tapered by a buildup of fatty deposits typically called as plaque, it can block theminimize the blood flow at times. If the blood flow is minimized and there is no supply to the heart muscle, chest pain can occur. With the forming of clot blockage occurs and if there is no blood flow to part of the heart muscle,resulting into aheart attack.
Stents ensure coronary arteries open and eliminate the chances of heart attack.When a stent is used, it’s collapsed and put over the balloon catheter. It’s then moved into the area of the blockage. When the balloon is exaggerated, the stent expands, locks in place and forms a scaffold. This holds the artery open to enable a free blood flow. This improves blood flow to the heart muscle and relieves symptoms.
The Coronary Stent Market is driven by growing geriatric population and sedentary lifestyle. Development of innovative and improved bioengineered absorbable products is also a key factor triggering industry growth.The Coronary Stent Market is classified, by type into Bare-metal Stents, Drug-eluting Stents (DES), and Bioabsorbable Stents. DES consisting biodegradable and non-biodegradable. DES headed the product segment.One of the benefits offered by DES is the ability to release antiproliferative drug that avoids neointimal proliferation, eventually reducing the incidence of stent restenosis. Moreover, the noninvasive procedure offered by DES is gaining popularity.
Conversely, BVS is expected to grow exponentially over the forecast period. The U.S. FDA approved first absorbable stent Absorb GT1 BVS for arterial disorder. This is manufactured with biodegradable polymer poly(L-lactide). BVS has added advantages of restoring vasomotor function, intensifying future treatment options, and helping avoid future complications with permanent devices. Some stents are coated with medicine that is slowly and continuously released into the artery. These stents are called drug-eluting stents. The medicine helps prevent the artery from becoming blocked again.Coronary Stent Market is classified, by mode of delivery into Balloon-expandable Stents, Self-expanding Stents.
The balloon expandable stents segment is expected to grow at highest CAGR during the forecast period due to the increasing research activities to improve this technology, high utilization of these stents, and growing regulatory approvals for balloon expandable stents.The Coronary Stent Market is classified, by material into Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, and Other Stents.The Coronary Stent Market is classified, by end user into Hospitals, Cardiac Centers, and Ambulatory Surgical Centers. Hospital segment is expected to lead the coronary stentmarket during the forecast period. This can mainly be accredited to high utilization of coronary stent in hospitals.The Coronary Stent Market is segmented, geographically into North America, Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa.
North America held largest market share of the coronary stentmarket and is expected to remain dominant over the forecast period. This is due to increasing occurrence of coronary arterial diseases, hypertension, and blockage of vessels is driving the growth of this market. Asia Pacific is predicted to be fastest growing region in the world in this vertical. Ease of doing business in this region, huge population, economic developments, and faster adoption rate of latest technologies governed the growth of this region. The key players in the coronary stent market key players are Abbott; Boston Scientific Corporation; Medtronic; B. Braun Melsungen AG; Terumo Corporation; Biotronik SE & Co. KG: Stentys SA; MicroPort Scientific Corporation; C. R. Bard, Inc.; and Cook Medical.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Coronary Stents in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Coronary Stents market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Abbott Laboratories
• Boston Scientific
• Terumo Corporati
• Lepu Medicalon
• B. Braun
• Atrium Medical
• Essen Technology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Bioresorbable Stent
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Cardiology Center
Research Support Specialist, USA